Abstract
Poly(ADP-ribose) polymerase 2 (PARP2) is a key sensor of DNA single-strand breaks that catalyzes ADP-ribosylation of itself and other substrates to initiate DNA repair. Human PARP2 contains an intrinsically disordered N-terminal domain (NTD) that mediates chromatin association and nuclear localization, a central WGR domain that recognizes DNA breaks, and a catalytic domain responsible for poly(ADP-ribose) synthesis. Despite its importance in genome maintenance and as a target of clinical PARP inhibitors, detailed information on the structural and dynamic properties of the NTD and WGR domains has remained limited. Here, we report the 1H, 13C, and 15N resonance assignments of the N-terminal intrinsically disordered region (residues 1–89) and the WGR domain (residues 90–212) of human PARP2. Resonance assignments were first obtained separately for each domain and subsequently transferred to a combined NTD–WGR construct. These assignments provide a foundation for future studies investigating the conformational dynamics, DNA recognition mechanisms, and allosteric regulation of PARP2 in chromatin and repair signaling.
Keywords: Poly(ADP-ribose) polymerase 2, PARP2 N-terminal intrinsically disordered domain, PARP2 WGR domain, PARP2 DNA binding domain, Solution NMR, Backbone resonance assignments
Biological context
Poly(ADP-ribose) polymerase 2 (PARP2) is a key enzyme in the base excision repair (BER) pathway that detects DNA single-strand breaks (SSBs) and catalyzes the synthesis of ADP-ribose polymers to recruit downstream repair factors (Amé et al. 1999; Ali et al. 2016; Chen et al. 2018; van Beek et al. 2021). Along with its paralog PARP1, PARP2 contributes to chromatin signaling during the DNA damage response and plays a critical role in maintaining genome stability (Amé et al. 2004; van Beek et al. 2021). Mutations or dysregulation of PARP2 have been implicated in cancer susceptibility and influence the cellular response to PARP inhibitors currently used in cancer therapy (Bryant et al. 2005; Murai et al. 2012; Ali et al. 2016).
Human PARP2 is composed of three major domains: an N-terminal intrinsically disordered domain (NTD) responsible for chromatin association and nuclear localization, a WGR (Trp-Gly-Arg) domain that mediates recognition of DNA breaks, and a C-terminal catalytic domain that carries out ADP-ribosylation (Meder et al. 2005; van Beek et al. 2021). The NTD contains a basic, low-complexity sequence that facilitates DNA-binding and has been shown to drive nuclear localization (Meder et al. 2005; Riccio et al. 2016). The WGR domain, in contrast, adopts a well-folded β-grasp topology that couples DNA binding to catalytic activation (Obaji et al. 2018). Together, these domains form a modular system that coordinates DNA damage recognition, chromatin engagement, and enzymatic activity (Bilokapic et al. 2020; Obaji et al. 2021; Smith-Pillet et al. 2025).
Despite its importance in genome maintenance and therapeutic targeting, detailed information on the structural and dynamic properties of the NTD and WGR domains has remained limited. Here, we report the 1H, 13C, and 15N backbone resonance assignments of the N-terminal intrinsically disordered region (residues 1–89) and the WGR domain (residues 90–212) of human PARP2. Assignments were first obtained separately for each domain and subsequently transferred to a combined NTD–WGR construct (1-212). These data provide the foundation for future investigations into the conformational dynamics, DNA recognition mechanisms, and allosteric regulation of PARP2 in chromatin and repair signaling.
Methods and experiments
Protein expression and purification
Cloning
The coding DNA sequences corresponding to the NTD, WGR, and NTD–WGR constructs were amplified by PCR using primers containing 5′ and 3′ overhangs complementary to the ends of the linearized pET-SUMO vector for Gibson assembly (NEB). Following amplification, PCR products were purified by gel extraction and inserted into the vector using Gibson assembly. The resulting plasmids were transformed into E. coli, and individual colonies were screened by Sanger sequencing to confirm the correct DNA sequences.
1H, 13C, 15N labeled NTD (1–89)
The plasmid encoding residues 1–89 of human PARP2 (UniProt ID: Q9UGN5) was transformed into E. coli BL21(DE3) CodonPlus RIPL cells (Agilent) and plated on LB agar containing chloramphenicol and kanamycin. Following overnight incubation at 37 °C, colonies were selected and grown in 100 mL of LB medium with the same antibiotics for 16 h at 37 °C. The culture was centrifuged (3000 x g, 10 min, 23 °C), and the cell pellet was resuspended in 1 L of M9 minimal medium (6 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NaCl, 1 g/L 15NH4Cl, pH 7.4) supplemented with 50 µg/mL kanamycin, 50 µg/mL chloramphenicol, 2 mM MgSO4, 0.1 mM CaCl2, 10 mg each of biotin and thiamine, and 4 g of 13C-glucose (Cambridge Isotope Laboratories). Cells were grown at 37 °C to an OD600 of 0.6, after which the temperature was reduced to 16 °C and incubation continued for 1 h prior to induction with 0.5 mM IPTG. Protein expression was carried out overnight at 16 °C. Following centrifugation (6000 x g, 30 min, 4 °C), the cell pellet was either stored at − 20 °C or processed immediately according to the following procedure.
The cell pellet was resuspended in lysis buffer (25 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole, 2 mM β-mercaptoethanol, pH 8.0) supplemented with a protease inhibitor cocktail (0.5 mM PMSF, 1 mM benzamidine-HCl, 0.5 µg/mL of aprotinin, antipain, leupeptin and pepstatin A) and lysed by sonication on ice (2 s on/2 s off cycles, 10 min total, 40% amplitude). The lysate was cleared by centrifugation (20,000 × g, 30 min, 4 °C), and the supernatant was loaded onto Ni-NTA resin pre-equilibrated with lysis buffer. The column was washed with 20 column volumes of lysis buffer, and the bound His–SUMO–NTD protein was eluted using elution buffer (25 mM Tris, 500 mM NaCl, 300 mM imidazole, 2 mM β-mercaptoethanol, pH 8.0). Eluted fractions were analyzed by SDS–PAGE, and the His–SUMO tag was cleaved using in-house–prepared ULP1 protease during dialysis against buffer (25 mM HEPES, 50 mM NaCl, 2 mM β-mercaptoethanol, pH 7.4). After ULP1 digestion, the sample was reapplied to a second Ni–NTA column in the presence of 30 mM imidazole to remove the affinity tag. Following confirmation of tag removal by SDS–PAGE, the sample was further purified using a HiTrap SP HP cation-exchange column (Cytiva) equilibrated with buffer A (25 mM HEPES, 2 mM β-mercaptoethanol, pH 7.4). Elution was performed using buffer B (25 mM HEPES, 1 M NaCl, 2 mM β-mercaptoethanol, pH 7.4) under a linear gradient from 0% to 100% buffer B over 50 mL. Fractions containing the NTD were pooled, concentrated, and subjected to size-exclusion chromatography using a HiLoad 16/600 Superdex 75 pg column (Cytiva) equilibrated with gel filtration buffer (25 mM Tris, 150 mM NaCl, 2 mM β-mercaptoethanol, pH 7.4). The purified NTD was buffer-exchanged into NMR buffer (25 mM MES, 2 mM DTT, 5% (v/v) D2O, pH 5.5) for NMR spectroscopy. The final protein concentration used for NMR data acquisition was 1.0 mM.
1H, 13C, 15N labeled WGR (90–212)
Procedures for expression and purification of uniformly 1H, 13C, 15N-labeled WGR (residues 90–212) were identical to those described for the NTD, except for the following modifications. Protein expression was induced at 20 °C instead of 16 °C. During purification, a HiTrap Heparin HP affinity column (Cytiva) was used in place of the HiTrap SP HP cation exchange column. The protein was buffer-exchanged into NMR buffer consisting of 25 mM MES, 4 mM TCEP and 5% (v/v) D2O (pH 5.5). The final protein concentration used for NMR data acquisition was 0.37 mM.
1H, 15N labeled NTD-WGR (1-212)
Procedures for expression and purification of uniformly 1H, 15N-labeled NTD–WGR (residues 1–212) were identical to those used for the WGR construct, with the following modifications. Due to the low expression yield, a total culture volume of 8 L of M9 minimal medium supplemented with 15NH4Cl and unlabeled glucose was required to obtain a single NMR sample in 25 mM MES, 4 mM TCEP and 5% (v/v) D2O (pH 5.5). For resonance assignment, chemical shift information from the individually assigned NTD and WGR domains was used to aid assignment of the 1H – 15N HSQC spectrum of the NTD–WGR construct. The final protein concentration for NMR data acquisition was 0.73 mM.
NMR spectroscopy
NMR samples of uniformly 1H, 13C, and 15N-labeled PARP2 NTD, and WGR constructs were prepared in 25 mM MES (pH 5.5) containing 4 mM TCEP/ 2 mM DTT and 5% (v/v) D2O. Final protein concentrations ranged from 0.4 to 1.0 mM. Approximately 350 µL of each sample was loaded into a 5 mm Shigemi tube for data collection. NMR experiments were performed at 288.15 K on a Bruker Avance NEO 700 MHz spectrometer equipped with a TCI cryoprobe optimized for 1H detection and controlled by TopSpin 4.2 software. Sequential backbone assignments were achieved using a conventional suite of triple resonance experiments, including HNCA, HNCACB, CBCA(CO)NH, HN(CO)CA, HNCO, HAHB(CBCACO)NH and HNN for sequential 1HN–15 N correlations (Panchal et al. 2001) in combination with 2D 1H,15N HSQC spectra. For the NTD–WGR construct, resonance correlations were cross-referenced with the independently assigned spectra of the NTD and WGR domains to confirm chemical shift consistency. Backbone assignments of the isolated NTD were initially obtained from triple-resonance experiments recorded at 283.15 K. For comparison with the NTD–WGR construct, additional HNCO spectra were recorded at 288.15 K, and assignments were transferred accordingly. Chemical shift data recorded at both temperatures have been deposited in the BMRB under accession number 53520. All spectra were processed using NMRPipe v2024.061.14.29 (Delaglio et al. 1995) and analyzed with CcpNmr Analysis v3.3.4 (Skinner et al. 2016). Non-uniformly sampled (NUS) datasets were reconstructed using the SMILE algorithm within the NMRPipe processing suite. Secondary structure (SS) probabilities were obtained from backbone chemical shifts using TALOS-N (Shen and Bax 2013).
Extent of assignment and data deposition
The 1H–15N HSQC spectra of the PARP2 NTD (residues 1–89, Fig. 1) and WGR (residues 90–212, Fig. 2) constructs displayed well-dispersed resonances, indicating monodisperse and properly folded states under the experimental conditions. Backbone resonance assignments for the NTD were obtained with substantial completeness, including 100% assignment of C′, Cα, and Cβ resonances. Assignment levels of 97.65% for HN and 94.32% for backbone 15N were achieved as determined using the assignment statistics module in CcpNmr Analysis. For the WGR domain, backbone assignments were also largely complete, with 100% assignment of C′ and 99.19% of Cα resonances. Assignment completeness was 99.17% for HN, 97.54% for 15N, 92.37% for Hα, 85.02% for Hβ and 93.04% for Cβ resonances. The indole N–H resonances of tryptophan side chains were assigned by site-directed mutagenesis, in which W148, W151, and W188 were individually mutated to tyrosine. Secondary structure predicted by TALOS-N for the NTD and WGR domains is shown in Figs. 1C and 2C, respectively. The NTD exhibits no significant secondary structure, consistent with its intrinsically disordered nature, and displays uniformly low RCI-S² values, indicative of high backbone dynamics. In contrast, the WGR domain exhibits strong β-strand and α-helical propensities, along with elevated TALOS-N predicted order parameters (RCI-S2 values ranging from 0.7 to 0.9), consistent with well-defined secondary structure elements and a rigid, folded architecture. Notably, although the crystal structure depicts residues 185–212 as largely unstructured, TALOS-N analysis of the NMR chemical shifts predicts some β-strand propensity in the C-terminal segment. Nevertheless, the TALOS-N secondary structure predictions for the WGR core domain overall are highly consistent with the X-ray crystal structure (Obaji et al. 2018). Secondary structure elements derived from the crystal structure were assigned using DSSP as implemented in PyMOL (Schrödinger, LLC). The domain architecture and corresponding secondary structure elements are shown in Fig. 2D; the representation was generated using IBM 2.0 (Liu et al. 2015).
Fig. 1.
Backbone assignments of the N-terminal domain (NTD) of PARP2. (A) Two-dimensional 1H–15N projection of the three-dimensional HNCO spectrum of the NTD (BMRB accession number 53520) recorded at 283.15 K, with assigned backbone amide resonances labeled. (B) Amino acid sequence of the NTD (residues 1–89). (C) Residue-wise RCI-S2 order parameters predicted by TALOS-N from Cα, Cβ, C’, and HN chemical shifts. TALOS-N analysis indicates predominantly coil propensity with no α-helical or β-sheet secondary structure across the sequence. The relatively low RCI-S2 values (green scatter plot) suggest increased backbone flexibility, consistent with the intrinsic disorder nature of the NTD
Fig. 2.
Backbone assignments of the WGR domain of PARP2. (A) Two-dimensional 1H–15N HSQC spectrum of the WGR domain (BMRB accession number 53521) recorded at 288.15 K, with assigned backbone amide resonances labeled. The resonance marked with an asterisk (*) is aliased in the displayed spectral window; its original position is at δ(¹⁵N) = 135 ppm. (B) Amino acid sequence of the WGR domain (residues 90–212). (C) Secondary structure probabilities derived from chemical shifts showing β-strands (red, plotted as negative values) and α-helices (blue); TALOS-N predicted RCI-S2 values are shown as green scatter points. (D) Secondary structure elements from the X-ray structure (PDB ID: 6F5F) derived using DSSP in PyMOL. The overall architecture agrees with the TALOS-N predictions
Assignments for the NTD–WGR construct were guided by the individually assigned NTD and WGR spectra (Fig. 3). Due to the low expression yield, which required approximately 8 L of M9 minimal medium to obtain a single 15N-labeled sample at sufficient concentration for NMR experiments, only the 1H, 15N-labeled construct was used for NMR experiments. For the NTD–WGR construct, backbone amide assignments were obtained for 160 residues. After excluding proline residues, this corresponds to approximately 78% assignment completeness. The remaining 45 missing assignments are distributed between the domains, with 14 residues in the NTD (residues 1–89) and 31 residues in the WGR domain (residues 90–212). In the NTD, missing assignments cluster around residues 81–89, where peaks shift or broaden in the NTD–WGR spectrum. In the WGR domain, most missing assignments arise from spectral overlap and reduced peak intensity.
Fig. 3.
Two-dimensional 1H–15N HSQC spectrum of the NTD–WGR construct (residues 1-212) of PARP2 recorded at 288.15 K (BMRB accession number 53522). Resonances labeled in red correspond to the NTD, and those labeled in blue correspond to the WGR domain. Assignments were transferred from spectra of the individual domains recorded at 288.15 K to the NTD–WGR construct. The resonance marked with an asterisk (*) is aliased in the displayed spectral window; its original position is at δ(¹⁵N) = 135 ppm
All assigned chemical shift data have been deposited in the Biological Magnetic Resonance Data Bank (BMRB) under accession numbers 53520 (NTD), 53521 (WGR), and 53522 (NTD–WGR).
Acknowledgements
This research was funded by the National Institutes of Health (R35GM154859), the Edward Mallinckrodt, Jr. Foundation, and Ohio Cancer Research. Additional support was provided by the American Cancer Society Institutional Research Grant (#IRG-16-186-21) to the Case Comprehensive Cancer Center. We thank Jeffrey P. Bonin, James M. Aramini, Lewis E. Kay (University of Toronto) for providing the NMR pulse programs used in this paper. We also thank Atul K. Srivastava for maintaining the 700 MHz spectrometer at Case Western Reserve University.
Author contributions
T.H.K. cloned the plasmids used for protein expression. R.K.V. purified and prepared the protein samples for NMR experiments. Both authors collected and analyzed the NMR data, wrote the manuscript, and approved the final version.
Data availability
The chemical shift assignments obtained in this study are available in the Biological Magnetic Resonance Data Bank (BMRB, http://bmrb.io) under accession number 53520 (NTD), 53521 (WGR), and 53522 (NTD-WGR).
Declarations
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- Ali SO, Khan FA, Galindo-Campos MA, Yélamos J (2016) Understanding specific functions of PARP-2: new lessons for cancer therapy. Am J Cancer Res 6:1842–1863 [PMC free article] [PubMed] [Google Scholar]
- Amé J-C, Rolli V, Schreiber V et al (1999) PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) Polymerase*. J Biol Chem 274:17860–17868. 10.1074/jbc.274.25.17860 [DOI] [PubMed] [Google Scholar]
- Amé JC, Spenlehauer C, De Murcia G (2004) The PARP superfamily. BioEssays 26:882–893. 10.1002/BIES.20085 [DOI] [PubMed] [Google Scholar]
- Bilokapic S, Suskiewicz MJ, Ahel I, Halic M (2020) Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin. Nature 585:609–613. 10.1038/s41586-020-2725-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bryant HE, Schultz N, Thomas HD et al (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913–917. 10.1038/nature03443 [DOI] [PubMed] [Google Scholar]
- Chen Q, Kassab MA, Dantzer F, Yu X (2018) PARP2 mediates branched poly ADP-ribosylation in response to DNA damage. Nat Commun 9:3233. 10.1038/s41467-018-05588-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Delaglio F, Grzesiek S, Vuister GW et al (1995) NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277–293. 10.1007/BF00197809 [DOI] [PubMed] [Google Scholar]
- Liu W, Xie Y, Ma J et al (2015) IBS: an illustrator for the presentation and visualization of biological sequences. Bioinformatics 31:3359–3361. 10.1093/bioinformatics/btv362 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meder VS, Boeglin M, de Murcia G, Schreiber V (2005) PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli. J Cell Sci 118:211–222. 10.1242/jcs.01606 [DOI] [PubMed] [Google Scholar]
- Murai J, Huang SN, Das BB et al (2012) Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res 72:5588–5599. 10.1158/0008-5472.CAN-12-2753 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Obaji E, Haikarainen T, Lehtiö L (2018) Structural basis for DNA break recognition by ARTD2/PARP2. Nucleic Acids Res 46:12154–12165. 10.1093/nar/gky927 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Obaji E, Maksimainen MM, Galera-Prat A, Lehtiö L (2021) Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition. Nat Commun 12:3479. 10.1038/s41467-021-23800-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Panchal SC, Bhavesh NS, Hosur RV (2001) Improved 3D triple resonance experiments, HNN and HN (C) N, for HN and 15 N sequential correlations in (13 C, 15 N) labeled proteins: application to unfolded proteins. J Biomol NMR 20(2):135–147 [DOI] [PubMed] [Google Scholar]
- Riccio AA, Cingolani G, Pascal JM (2016) PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage. Nucleic Acids Res 44:1691–1702. 10.1093/nar/gkv1376 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shen Y, Bax A (2013) Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J Biomol NMR 56:227–241. 10.1007/s10858-013-9741-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skinner SP, Fogh RH, Boucher W et al (2016) CcpNmr AnalysisAssign: a flexible platform for integrated NMR analysis. J Biomol NMR 66:111–124. 10.1007/s10858-016-0060-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith-Pillet ES, Billur R, Langelier M-F et al (2025) A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation. Mol Cell 85:865–876e4. 10.1016/j.molcel.2025.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- van Beek L, McClay É, Patel S et al (2021) PARP Power: A structural perspective on PARP1, PARP2, and PARP3 in DNA damage repair and nucleosome remodelling. Int J Mol Sci 22. 10.3390/ijms22105112 [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The chemical shift assignments obtained in this study are available in the Biological Magnetic Resonance Data Bank (BMRB, http://bmrb.io) under accession number 53520 (NTD), 53521 (WGR), and 53522 (NTD-WGR).



